Novartis India
₹1,043.35
-22.85 (-2.14%)
14 May, 2024 01:26 BSE: 500672
NSE: NOVARTINDISIN: INE234A01025
Start SIP in Novartis India
Start SIPNovartis India Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Novartis India Financials
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 81 | 85 | 79 | 91 | 76 |
| Operating Expenses Qtr Cr | 70 | 65 | 62 | 73 | 67 |
| Operating Profit Qtr Cr | 11 | 20 | 17 | 17 | 9 |
| Depreciation Qtr Cr | 0 | 0 | 1 | 2 | 2 |
| Interest Qtr Cr | 0 | 0 | 1 | 0 | 0 |
| Tax Qtr Cr | 7 | 15 | 9 | 8 | -2 |
| Net Profit Qtr Cr | 15 | 27 | 24 | 20 | 25 |
Novartis India Technicals
EMA & SMA
Current Price
₹1,043.35
-22.85 (-2.14%)
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹1,046.34
- 50 Day
- ₹1,014.51
- 100 Day
- ₹953.39
- 200 Day
- ₹872.39
- 20 Day
- ₹1,043.18
- 50 Day
- ₹1,013.57
- 100 Day
- ₹944.77
- 200 Day
- ₹828.81
Novartis India Resistance and Support
PIVOT
₹1,041.07
| Resistance | |
|---|---|
| First Resistance | 1,057.13 |
| Second Resistance | 1,070.92 |
| Third Resistance | 1,086.98 |
| RSI | 50.95 |
| MFI | 61.17 |
| MACD Single Line | 11.86 |
| MACD | 10.78 |
| Support | |
|---|---|
| First Resistance | 1,027.28 |
| Second Resistance | 1,011.22 |
| Third Resistance | 997.43 |
Novartis India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 52,985 | 3,935,196 | 74.27 |
| Week | 23,574 | 1,805,768 | 76.6 |
| 1 Month | 15,774 | 1,104,507 | 70.02 |
| 6 Month | 30,152 | 1,916,184 | 63.55 |
Novartis India Result Highlights
Novartis India Synopsis
NSE-Medical-Diversified
Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 378.74 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2023. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.| Market Cap | 2,548 |
| Sales | 335 |
| Shares in Float | 0.72 |
| No of funds | 38 |
| Yield | 1.49 |
| Book Value | 3.54 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | |
| Alpha | 0.08 |
| Beta | 0.68 |
Novartis India
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 70.68% | 70.68% | 70.68% | 70.68% |
| Mutual Funds | ||||
| Insurance Companies | 0.51% | 0.51% | 0.51% | 0.74% |
| Foreign Portfolio Investors | 0.19% | 0.19% | 0.32% | 0.23% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 22.95% | 23.2% | 23.29% | 23.09% |
| Others | 5.66% | 5.41% | 5.19% | 5.25% |
Novartis India Management
| Name | Designation |
|---|---|
| Mr. Christopher Snook | Chairman |
| Mr. Sanjay Murdeshwar | Vice Chairman & Mng.Director |
| Ms. Shilpa Joshi | WholeTime Director & CFO |
| Ms. Sandra Martryes | Independent Director |
| Mr. Jai Hiremath | Independent Director |
| Mr. Sanker Parameswaran | Independent Director |
Novartis India Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Novartis India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-10 | Audited Results & Final Dividend | |
| 2024-01-25 | Quarterly Results | |
| 2023-10-27 | Quarterly Results | |
| 2023-07-26 | Quarterly Results | |
| 2023-05-10 | Audited Results, Final & Special Dividend |
Novartis India FAQs
What is Share Price of Novartis India ?
Novartis India share price is ₹1,043 As on 14 May, 2024 | 01:12
What is the Market Cap of Novartis India ?
The Market Cap of Novartis India is ₹2576.1 Cr As on 14 May, 2024 | 01:12
What is the P/E ratio of Novartis India ?
The P/E ratio of Novartis India is 30.2 As on 14 May, 2024 | 01:12
What is the PB ratio of Novartis India ?
The PB ratio of Novartis India is 3.5 As on 14 May, 2024 | 01:12